Array Biopharma Shares Down 15.6% Since SmarTrend's Sell Call (ARRY)
July 30, 2015 at 12:53 PM EDT
SmarTrend identified a Downtrend for Array Biopharma (NASDAQ:ARRY) on April 28th, 2015 at $6.68. In approximately 3 months, Array Biopharma has returned 15.64% as of today's recent price of...
